Literature DB >> 1465773

Indefinite survival of MHC class I-deficient murine pancreatic islet allografts.

J F Markmann1, H Bassiri, N M Desai, J S Odorico, J I Kim, B H Koller, O Smithies, C F Barker.   

Abstract

To examine the immune response to class I-deficient allogeneic tissue, we used beta 2-microglobulin-deficient mice as graft donors. These mice lack cell surface class I major histocompatibility complex antigen expression. Pancreatic islet allografts from class I-deficient donors survived indefinitely in a majority of fully allogeneic BALB/c recipients. In contrast, host recognition of graft class I antigen was unnecessary for prompt destruction of skin allografts of for autoimmune damage of transplanted pancreatic islet grafts in nonobese diabetic mice. These studies provide evidence that intentional genetic elimination of immunologically relevant donor antigens may prove an effective strategy for preventing allograft rejection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465773     DOI: 10.1097/00007890-199212000-00025

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  18 in total

1.  CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.

Authors:  B A Pietra; A Wiseman; A Bolwerk; M Rizeq; R G Gill
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

2.  Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes.

Authors:  M G von Herrath; S Efrat; M B Oldstone; M S Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Reversal of established autoimmune diabetes by restoration of endogenous beta cell function.

Authors:  S Ryu; S Kodama; K Ryu; D A Schoenfeld; D L Faustman
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 4.  The Nexus of Stem Cell-Derived Beta-Cells and Genome Engineering.

Authors:  Sara D Sackett; Aida Rodriguez; Jon S Odorico
Journal:  Rev Diabet Stud       Date:  2017-06-12

5.  Prevention of xenograft rejection by masking donor HLA class I antigens.

Authors:  J Piniés; L Castaño; P Colman
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

6.  Rapid detection of homologous recombinants in nontransformed human cells.

Authors:  S R Williams; F C Ousley; L J Vitez; R B DuBridge
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

Review 7.  Pancreatic islet xenotransplantation: barriers and prospects.

Authors:  Gina R Rayat; Ronald G Gill
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

8.  HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications.

Authors:  Zaruhi Karabekian; Hao Ding; Gulnaz Stybayeva; Irina Ivanova; Narine Muselimyan; Amranul Haque; Ian Toma; Nikki G Posnack; Alexander Revzin; David Leitenberg; Michael A Laflamme; Narine Sarvazyan
Journal:  Tissue Eng Part A       Date:  2015-09-10       Impact factor: 3.845

9.  Pretreatment of donor islets with papain improves allograft survival without systemic immunosuppression in mice.

Authors:  Kenjiro Kumano; Hitomi Nishinakamura; Toshiyuki Mera; Takeshi Itoh; Hiroyuki Takahashi; Toshiyoshi Fujiwara; Shohta Kodama
Journal:  Islets       Date:  2016-09-02       Impact factor: 2.694

10.  CD4+ T cells are sufficient to elicit allograft rejection and major histocompatibility complex class I molecule is required to induce recurrent autoimmune diabetes after pancreas transplantation in mice.

Authors:  Zhidan Xiang; Lian-Li Ma; Santhakumar Manicassamy; Balaji B Ganesh; Phillip Williams; Ravi Chari; Anita Chong; Deng-Ping Yin
Journal:  Transplantation       Date:  2008-04-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.